期刊文献+

基质金属蛋白酶-9和表皮生长因子受体在非小细胞肺癌中的表达及临床意义 被引量:3

Expression and biological significance of MMP-9 and EGFR in patients with non-small cell lung cancer
在线阅读 下载PDF
导出
摘要 目的:了解非小细胞肺癌(NSCLC)组织中基质金属蛋白酶-9(MMP-9)和表皮生长因子受体(EGFR)蛋白的表达及其与肺癌组织类型、细胞分化和淋巴结转移的关系。方法:应用S-P免疫组化的方法检测38例非小细胞肺癌组织和10例正常肺组织中MMP-9和EGFR蛋白的表达。结果:38例NSCLC中MMP-9蛋白的阳性表达率为78·9%(30/38),而中度至强阳性的表达率为60·5%(23/38),与正常对照组比较有显著性差别(P<0·05),其中鳞癌、腺癌MMP-9蛋白的阳性表达率分别为60·0%(12/20)和88·9%(16/18)(P<0·05);有纵隔淋巴结转移组肿瘤组织MMP-9阳性表达率93·3%(28/30),显著高于无纵隔淋巴结转移组50·0%(4/8)(P<0·05);中低分化肿瘤组织MMP-9阳性表达率为80·8%(21/26),明显高于高分化肿瘤组织58·3%(7/12)(P<0·05)。EGFR蛋白在38例NSCLC的表达率为57·9%(22/38),在正常肺组织表达为阴性,二者比较有显著性差异(P<0·05),其中鳞癌、腺癌EGFR蛋白的阳性表达率分别为45·0%(9/20)和72·2%(13/18),二者比较无显著性差异(P>0·05)。有纵隔淋巴结转移组EGFR阳性表达率56·7%(17/30),显著高于无淋巴结转移组37·5%(3/8)(P<0·05);中低分化肿瘤组织MMP-9阳性表达率为69·2%(18/26),明显高于高分化肿瘤组织33·3%(4/12)(P<0·05)。MMP-9和EGFR蛋白在Ⅲ期NSCLC中共同表达率占44·7%(17/38),显著高于Ⅰ期和Ⅱ期患者的13·1%(5/38)。结论:NSCLC中MMP-9蛋白的表达与肺癌的病理分型、细胞分化及淋巴结转移有关;EGFR蛋白的表达和肺癌的TNM分期和淋巴结的转移有关;提示EGFR的信号转导与MMP-9在肿瘤浸润和转移过程中发挥重要作用,MMP-9和EGFR的共同高表达是肺癌不良预后的指标。 Objective :To investigate the expression and biological significance of MMP-9 and EGFR in 38 NSCLC patients and 10 cases normal lung tissues in order to seek their relationship between them and the prognostic significance. Methods: Tissues were obtained from 38 cases in NSCLC and 10 cases normal lung tissue. The expression of MMP-9 and EGFR were examined by immunohistochemical technique (streptavidin-peroxidase conjugate method, S-P) and the results were correlated with clinical pathological tumor parameters. Results:The positive expression of MMP-9 and EGFR in 38 cases NSCLC were 78.9% (30/38) and 57.9% (22/ 38 ) respectively which was significantly higher than that in normal lung tissues ( P〈0. 05 ). The positive expression of MMP-9 protein was related with histological classification cell differentiation and also related to lymph node metastasis ( P 〈 0.05 ), The positive expression of EGFR protein was not related to histological classification, but it was related to lymph node metastasis and cell differentiation ( P〈0. 05 ). The rate of MMP-9 protein and EGFR protein co-expression in stage Ⅲ NSCLC was 44. 7% ( 17/38 ) , and the expression of M MP-9 and EGFR was significantly higher than that in stage Ⅰ and stage Ⅱ ( 13. 1% ,5/38). Conclusion: MMP-9 and EGFR may play important roles in NSCLC invasion and metastasis. Over expression of MMP-9 and EGFR protein in NSCLC could act as a reference to evaluate metastasis and unfavourable prognosis of NSCLC.
出处 《临床肿瘤学杂志》 CAS 2005年第6期561-564,共4页 Chinese Clinical Oncology
基金 国家人事部留学回国人员科研启动基金项目(批准号:国人部发[2003]50号)
关键词 非小细胞肺癌 免疫组织化学 基质金属蛋白酶-9 表皮生长因子受体 NSCLC Immunohistochemistry Matrix metalloproteinase-9 EGFR
  • 相关文献

参考文献10

  • 1孙燕.现代肿瘤学[M].北京:人民卫生出版社,2001.994.
  • 2Fang J,Shing Y,Wiederschain D,et al.Matri metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model[J].Proc Natl Acad Sci USA,2002,97 (8) :3884.
  • 3Davies B,Waxman J,Wasan H,et al.Levels of matrix metalloproteinases in bladder cancer with tumor grade and invasion[J].Cancer Research,1993,53 (22) :5365 - 5369.
  • 4Canning MI,Postovit LM,Clarke SH,et al.Oxygen-mediated regulation of gelatinase and tissue inhibitor for metalloproteinase-1expression by invasive cells[J].Exp Cell Res,2001,267(1) :88-94.
  • 5Sienel W,Hellers J,Morresi-Hauf A.Prognostic impact of matrix metalloproteinase-9 in operable non-small cell lung cancer[J].Int J Cancer,2003,103(5) :647 -651.
  • 6Ciardiello F,Tortora G.A novel approach in the treatment of cancer:targeting the epidermal growth factor receptor[J].Clin Cancer Res,2001,7(10) :2958 -2970.
  • 7Masairo Tateishi,Teruyoshi Ishida,et al.Immunohistochemical evidence of autocrine growth factor in adenocarcinoma of the human lung[J].Cancer Research,1990,50:7077 - 7080.
  • 8李新举,梁景仁,武萌,邓元.EGFR和C-erbB2蛋白在非小细胞肺癌中的表达及其临床意义[J].西安交通大学学报(医学版),2003,24(2):150-153. 被引量:9
  • 9Pfeiffer P,Nexo E,Bentzen SM.Enzyme-linked immunosorbent assay of epidermal growth factor receptor in lung cancer:comparisons with immunohistochemistry,clinicopathological features and prognosis[J].Br J Cancer,1998,78(1) :96 -99.
  • 10Giles Cox J,Louise Jones,Kenneth J,et al.Matrix metalloproteinase 9 and the epidermal growth factor signal pathway in operable non-small cell lung Cancer [J].Clinical Cancer Research,2000,6(6) :2349 -2355.

二级参考文献1

  • 1张迺蘅.医学分子生物学[M].北京:北京医科大学出版社,1999.577-644.

共引文献8

同被引文献25

  • 1朱婷,江蓓蕾,江茜,李玉芝,鲍扬漪.自体CIK细胞治疗对中晚期非小细胞肺癌患者免疫功能及生活质量的影响[J].中国肿瘤生物治疗杂志,2015,22(1):84-88. 被引量:18
  • 2蒋南川,王孝英,冯敢生,韩萍,梁波,田志梁,雷子乔.周围型肺癌CT征象与MMP-2和VEGF表达相关性研究[J].中国医学影像技术,2004,20(9):1376-1378. 被引量:6
  • 3蔡绥勍,陈丽荣,王海军,姚丽芳,郑敏.磷酸化信号传导和转录激活因子3和上皮钙黏着蛋白在表皮肿瘤的表达[J].中华皮肤科杂志,2005,38(2):86-88. 被引量:7
  • 4Davies B, Waxman S, Wasan H, et al. Levels of mat ix metallo-proteinases in bladder cancer with tumor grade and invasion [J]. Cancer Research, 1993, 53 (22): 5365-5369.
  • 5Uffmann M, Prokop M. Multislice CT of the lung. Technique and clinical applications [J]. Radiology, 2001, (3) : 240-247.
  • 6Shou Y, Hirano T, Gong Y,et al. Influence of anglogenetic factors and maMx metalloproteinases upon cancer[J]. Br J Cancer, 2001, 85: 1706-1712.
  • 7Masairo Tateishi, Teruyoshi Ishida, Comark Bashll. Immunohisto chemical evidence of antocri e growth factor in ad of the human lung[J]. Cancer Research,1990,50:7077-7080.
  • 8Nowell PC. Mechanisms of tumor progression [J]. Cancer Res, 1986,46:2203-2207.
  • 9Mathew J,Hines JE,Obafunwa JO,et al.CD44 is expressed in hepatocellular carcinomas showing vascular invasion[J].J Pathol,1996,179(1):74-79.
  • 10Samantaray S,Sharma R,Chattopadhyaya TK,et al.Increased expression of MMP-2 and MMP-9 in esophageal squamous cell carcinoma[J].J Cancer Res Clin Oncol.2004,130(1):37-44.

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部